3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
170
Prostatic Neoplasms, Castration-Resistant
11
Neoplasm Metastasis
11
Metastatic Castration-resistant Prostate Cancer
7
Metastatic Castration Resistant Prostate Cancer
6
Prostate Cancer Metastatic
4
Neoplasms
4
Metastatic Castration-Resistant Prostate Cancer
4
Urogenital Neoplasms
3
Genital Neoplasms, Male
3
Prostatic Diseases
2
Neoplasms by Site
2
Metastatic Castration-resistant Prostate Cancer (mCRPC)
2
Genital Diseases, Male
2
Castration-resistant Prostate Cancer
2
Adenocarcinoma
2
Urinary Bladder Neoplasms
1
Stage II Prostate Adenocarcinoma
1
Sleep Initiation and Maintenance Disorders
1
Prostate Adenocarcinoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oligometastatic Prostate Carcinoma
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neoadjuvant Therapy
1
NSCLC Harboring NRG1 Fusion
1
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
1
Metastatic Hormone Refractory Prostate Cancer
1
Metastatic Castration-sensitive Prostate Cancer
1
Metastatic Castration-resistent Prostate Cancer
1
Metastatic Castration-resistant Prostate Neoplasms
1
Interventions
Cognitive Behavioral Therapy
2
enzalutamide
1
darolutamide
1
apalutamide
1
Zolpidem
1
Mindfulness-Based Stress Reduction
1
Exercise
1
Electrocardiography
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sleep Initiation and Maintenance Disorders
×
Abiraterone Acetate
×
Genitourinary
×
Clear all
NCT07181122
2026-04-28
PRO-MIND
Ankara Etlik City Hospital
Recruiting
102 enrolled